Trust Company of Toledo’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Trust Company of Toledo’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17	Closed	-$12.1K	–	224
2023 Q3	$12.1K	Sell	17 -1	-6%	-$4.29K	﹤0.01%	212
2023 Q2	$83K	Buy	18 +4	+29%	+$13.9K	0.01%	196
2023 Q1	$38K	Buy	+14	New	+$41K	0.01%	200

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Trust Company of Toledo's SEEL Position: Q4 2023 in Review

Trust Company of Toledo sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 17 shares — an estimated $12.1K sold.

Trust Company of Toledo first reported a position in SEEL in Q1 2023 and held it in 3 quarters. The position peaked at $83K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

Trust Company of Toledo reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Trust Company of Toledo sold 17 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $12.1K.
Trust Company of Toledo first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Trust Company of Toledo's Seelos Therapeutics, Inc. Common Stock position peaked at $83K in Q2 2023.
32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Trust Company of Toledo's 13F filing for Q4 2023, filed 4 Jan 2024.